Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Mesa Laboratories Inc

MLAB
Current price
104.6 USD -2.53 USD (-2.36%)
Last closed 107.77 USD
ISIN US59064R1095
Sector Technology
Industry Scientific & Technical Instruments
Exchange NASDAQ
Capitalization 645 469 952 USD
Yield for 12 month +11.55 %
1Y
3Y
5Y
10Y
15Y
MLAB
21.11.2021 - 28.11.2021

Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. The Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. The Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems, offered under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado. Address: 12100 West Sixth Avenue, Lakewood, CO, United States, 80228

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

143.33 USD

P/E ratio

Dividend Yield

0.61 %

Current Year

+216 187 000 USD

Last Year

+219 080 000 USD

Current Quarter

+57 833 000 USD

Last Quarter

+58 170 000 USD

Current Year

+110 759 000 USD

Last Year

+133 693 000 USD

Current Quarter

+35 455 000 USD

Last Quarter

+33 835 000 USD

Key Figures MLAB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 41 608 000 USD
Operating Margin TTM 6.85 %
PE Ratio
Return On Assets TTM 1.69 %
PEG Ratio
Return On Equity TTM -89.46 %
Wall Street Target Price 143.33 USD
Revenue TTM 228 380 000 USD
Book Value 29.79 USD
Revenue Per Share TTM
Dividend Share 0.64 USD
Quarterly Revenue Growth YOY 8.8 %
Dividend Yield 0.61 %
Gross Profit TTM 116 552 000 USD
Earnings per share -45.62 USD
Diluted Eps TTM -45.62 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY 387.5 %
Profit Margin -107.56 %

Dividend Analytics MLAB

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

179 %

Dividend History MLAB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 0.64
Ex Dividend Date 29.11.2024
Forward Annual Dividend Yield 0.54 %
Last Split Factor
Payout Ratio 11.51 %
Last Split Date
Dividend Date 16.12.2024

Stock Valuation MLAB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 35.2113
Enterprise Value Revenue 3.6955
Price Sales TTM 2.8263
Enterprise Value EBITDA 305.6549
Price Book MRQ 3.9979

Financials MLAB

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators MLAB

For 52 weeks

83.58 USD 141 USD
50 Day MA 124.64 USD
Shares Short Prior Month 150 955
200 Day MA 111.2 USD
Short Ratio 6.23
Shares Short 168 561
Short Percent 4.54 %